Annovis BioAdvance News Portfolio News

Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68 Parkinson’s and Alzheimer’s Patients

By WebmasterApril 30, 2020November 1st, 2024No Comments

Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68 Parkinson’s and Alzheimer’s Patients

Previous PostKeriton Kare Selected by Connecticut Children's to Improve Quality and Safety of Feeding Management in Its NICU and PICU
Next PostVenatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options